NovelStem International Corp. is a development stage biotechnology holding company that focuses on the development and commercialization of stem cell-based diagnostic technology. The company aims to predict patients' anti-cancer drug resistance and has been involved in research collaborations for cancer immunotherapy and COVID-19 resistance.
Focus Areas
Notable Investments
